Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 2,737–2,744 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Merck & Company Inc. ALX148 and KEYTRUDA (pembrolizumab) - (ASPEN-03) Head and neck squamous cell carcinoma (HNSCC) Phase 2 Trial Discontinued Intravenous Oncology
Merck & Company Inc. Sotatercept - (SPECTRA) Pulmonary arterial hypertension (PAH) Phase 2 Data Released Subcutaneous Cardiology
Merck & Company Inc. Ensifentrine (RPL554) - Metered Dose Inhaler Chronic obstructive pulmonary disease (COPD) Phase 2 Trial Completed Inhalation Respiratory
Merck & Company Inc. MK-8591 HIV Phase 2 oral Anti-HIV
Merck & Company Inc. Ensifentrine (RPL554) DPI formulation Maintenance treatment of COPD Phase 2 Trial Discontinued Inhalation Respiratory
Merck & Company Inc. Rezafungin (CD101) - (STRIVE B) Candidemia Phase 2 Trial Completed Intravenous Anti-Fungal
Merck & Company Inc. Dalantercept - (DART) Renal Cell Carcinoma (RCC) - cancer Phase 2 Intravenous Oncology
Merck & Company Inc. ACE-083 Facioscapulohumeral muscular dystrophy Phase 2 Intramuscular Genetic Disorder